+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Glucose Testing Market - Global Forecast to 2030- Product Image
Blood Glucose Testing Market - Global Forecast to 2030- Product Image
Sale

Blood Glucose Testing Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5094051
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Glucose Testing Market grew from USD 21.21 billion in 2024 to USD 23.40 billion in 2025. It is expected to continue growing at a CAGR of 9.83%, reaching USD 37.24 billion by 2030.

Blood glucose testing has emerged as a cornerstone of modern diabetes management, enabling timely interventions and personalized care plans. As the prevalence of diabetes continues to rise globally, healthcare providers, technology developers, and policymakers are rallying to improve device accuracy, patient adherence, and data integration. Innovations in sensing technologies and digital connectivity now empower patients to track glycemic trends in real time, transforming the daily routines of millions into actionable insights. This executive summary explores the critical drivers shaping the blood glucose testing market, evaluates policy shifts impacting cost and accessibility, and highlights segmentation patterns that illuminate unmet needs across diverse user groups. By examining regional dynamics and profiling industry leaders, we reveal opportunities to optimize supply chains, enhance clinical outcomes, and deliver value across the healthcare ecosystem. Through actionable recommendations, we aim to equip decision-makers with strategic guidance to navigate regulatory complexity, foster collaboration, and drive patient-centric innovation in this rapidly evolving field.

Transformative Shifts in the Landscape

The landscape of blood glucose testing has undergone transformative shifts, spurred by digital health integration, regulatory modernization, and evolving patient expectations. Integration of continuous glucose monitoring devices with smartphones and cloud platforms has elevated real-time data sharing, empowering clinicians to intervene proactively. Advances in artificial intelligence now enable predictive analytics to identify glycemic excursions before they occur, reducing the burden of manual data review. Furthermore, the expansion of telemedicine accelerated by the pandemic has entrenched remote monitoring as a standard of care, prompting payers to refine reimbursement pathways for home-based testing. Concurrently, regulatory agencies have streamlined approval processes for breakthrough sensor technologies, encouraging a surge of novel, minimally invasive devices. This convergence of technological innovation, policy reform, and patient-centric care models is redefining the blood glucose testing paradigm, shifting focus from reactive measurement to predictive, personalized management.

Cumulative Impact of United States Tariffs 2025

Implementation of new U.S. tariffs in 2025 has imposed a cumulative impact on blood glucose testing devices and components, challenging manufacturers to reevaluate sourcing strategies. Increased duties on imported sensors, transmitters, and testing consumables have driven raw material costs upward, prompting contract renegotiations and price adjustments. Suppliers faced supply chain disruptions as they scrambled to comply with updated customs requirements, leading some to absorb duties temporarily to maintain market share. In response, leading OEMs have accelerated localization of assembly operations and forged partnerships with domestic component producers to mitigate exposure to tariff volatility. Diversification of supplier networks and strategic inventory management have become critical risk-management tactics. Despite short-term cost pressures, these adaptations are fostering more resilient manufacturing footprints and enhancing long-term supply security in a fluctuating trade environment.

Key Segmentation Insights

The blood glucose testing market is characterized by multifaceted segmentation, revealing distinct growth drivers and unmet needs across product, patient, technology, end-user, application, component, distribution, and age categories. Product type divides the landscape into continuous glucose monitoring devices-comprising receivers, sensors, and transmitters-and self-monitoring blood glucose devices, which include meters, lancets, and test strips. Patient segmentation distinguishes individuals with type 1 diabetes, segmented into adults and children, from patients with type 2 diabetes, categorized as managed or newly diagnosed. Technology segmentation encompasses electrochemical, photometric, and spectroscopy-based systems. End-user segmentation spans diagnostic centers-covering emergency and routine diagnostics-homecare settings for self-use, hospitals and clinics with inpatient and outpatient testing, and research laboratories focused on clinical research and product development. Application segmentation addresses daily tracking through routine monitoring, emergency monitoring in critical care environments, and long-term monitoring for clinical evaluation. Component segmentation highlights hardware in devices and integrated systems, services including installation, setup, maintenance, and warranty, and software via mobile and web-based platforms. Distribution channels range from in-hospital pharmacies and e-commerce platforms to retail pharmacies-both chain and independent outlets. Finally, age group segmentation spans adults (young and middle-aged), geriatrics (elderly) and pediatrics (adolescents, children, and neonates), underscoring the necessity for tailored design, usability, and support across life stages.

Key Regional Insights

Regional dynamics reveal differentiated adoption patterns and regulatory frameworks that shape market potential. In the Americas, established reimbursement systems and high consumer awareness have driven rapid uptake of continuous glucose monitoring solutions, particularly in urban centers, where telehealth integration accelerates home-based testing. North American manufacturers benefit from robust R&D ecosystems, while Latin American markets are poised for growth as public health initiatives expand diabetes screening programs. In Europe, Middle East & Africa, harmonized regulatory pathways in the European Union facilitate cross-border product launches, yet local reimbursement variances require region-specific market access strategies. The Middle East is witnessing rising demand for mobile-enabled devices, whereas parts of Africa rely heavily on low-cost self-monitoring kits distributed through public health channels. In the Asia-Pacific region, a burgeoning diabetic population and rapidly modernizing healthcare systems in countries such as China and India are driving demand for affordable, scalable glucose monitoring solutions. Partnerships with local distributors and tiered pricing models are proving effective for market penetration across diverse socioeconomic segments.

Key Companies Insights

A competitive landscape analysis highlights the strategic positioning and innovation trajectories of leading industry players. 77 Elektronika Kft. has carved a niche in advanced sensor calibration, while Abbott Laboratories leverages its ecosystem of wearable platforms and cloud analytics to enhance patient engagement. ACON Laboratories, Inc. and AgaMatrix, Inc. focus on cost-effective meter technologies optimized for emerging markets. ARKRAY, Inc. and Ascensia Diabetes Care Holdings AG continue to refine sensor accuracy and reduce calibration requirements, while B. Braun Medical Ltd. and Becton Dickinson and Company expand service offerings through integrated supply chain solutions. Beurer Belgium and ForaCare Suisse AG emphasize user-friendly design in portable meters, whereas Dexcom, Inc. leads in continuous glucose monitoring innovation. i-SENS, Inc. develops disposable biosensors with rapid response times, and Johnson & Johnson’s LifeScan IP Holdings, LLC remains a key player in legacy meter technology. Medisana AG and Medtronic PLC are advancing automated insulin delivery integration, while Merck KGaA applies its materials science expertise to novel sensing substrates. Microlife AG and Neogen Corporation explore multiplexed diagnostic platforms, Nipro Corporation and Nova Biomedical invest in miniaturization, and Omron Healthcare, Inc. integrates blood pressure and glucose tracking for comprehensive cardiovascular risk management. Roche Diagnostics Nederland BV pioneers seamless data aggregation, Rossmax International Ltd. focuses on telehealth connectivity, Sanofi S.A. partners on patient support programs, Sinocare Inc. and Terumo Corporation target affordable solutions for rural settings, and Trividia Health, Inc. and VivaChek Laboratories Inc. accelerate geographic expansion through regional alliances.

Actionable Recommendations for Industry Leaders

Industry leaders can capitalize on emerging trends and mitigate risks by adopting a series of targeted actions. First, accelerating localization of manufacturing and assembly can reduce tariff exposure and shorten supply chains. Second, investing in integrated digital platforms that seamlessly combine continuous monitoring data with telehealth services will enhance patient adherence and clinical outcomes. Third, forming collaborative partnerships with payers to demonstrate real-world value through outcomes-based contracts will secure favorable reimbursement terms. Fourth, diversifying product portfolios to include lower-cost, high-accuracy self-monitoring kits will capture underserved markets in emerging economies. Fifth, adopting modular design principles for hardware and software will facilitate rapid customization for different end-user segments and regulatory environments. Sixth, implementing predictive maintenance and remote device diagnostics within service offerings can reduce downtime and improve customer satisfaction. Finally, leveraging advanced analytics to identify patient subpopulations and tailor educational resources will drive engagement and loyalty.

Conclusion

In summary, the blood glucose testing market stands at a pivotal juncture, shaped by technological innovation, evolving regulatory landscapes, and shifting patient expectations. While U.S. tariffs present near-term cost challenges, they also incentivize resilient supply chain strategies and domestic partnerships. Segmentation analysis underscores the importance of addressing diverse needs-from continuous monitoring for tech-savvy adults to affordable self-testing solutions for underserved populations. Regional insights reveal that tailored market access approaches and strategic alliances will drive adoption across the Americas, EMEA, and Asia-Pacific. A deep understanding of competitive dynamics among top players is crucial for identifying collaboration, acquisition, and co-development opportunities. By aligning product development, digital integration, and value demonstration with stakeholder priorities, industry leaders can deliver meaningful improvements in patient outcomes and capture sustainable growth in this dynamic landscape.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Testing Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Continuous Glucose Monitoring Devices
    • Receivers
    • Sensors
    • Transmitters
  • Self-Monitoring Blood Glucose Devices
    • Blood Glucose Meters
    • Lancets
    • Test Strips
  • Patients With Type 1 Diabetes
    • Adults
    • Children
  • Patients With Type 2 Diabetes
    • Managed
    • Newly Diagnosed
  • Electrochemical
  • Photometric
  • Spectroscopy Based
  • Diagnostic Centers
    • Emergency Diagnostics
    • Routine Diagnostics
  • Homecare Settings
    • Home Self-Use
  • Hospitals and Clinics
    • Inpatient Testing
    • Outpatient Testing
  • Research Laboratories
    • Clinical Research
    • Product Development
  • Daily Tracking
    • Routine Monitoring
  • Emergency Monitoring
    • Critical Care Monitoring
  • Long-Term Monitoring
    • Clinical Evaluation
  • Hardware
    • Devices
    • Integrated Systems
  • Services
    • Installation and Setup
    • Maintenance and Warranty
  • Software
    • Mobile Applications
    • Web-Based Platforms
  • Hospital Pharmacies
    • In-Hospital Pharmacies
  • Online Channels
    • E-Commerce Platforms
  • Retail Pharmacies
    • Chain Pharmacies
    • Independent Pharmacies
  • Adults
    • Middle-Aged
    • Young Adults
  • Geriatrics
    • Elderly
  • Pediatrics
    • Adolescents
    • Children
    • Neonates

This research report categorizes the Blood Glucose Testing Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Blood Glucose Testing Market to delves into recent significant developments and analyze trends in each of the following companies:

  • 77 Elektronika Kft.
  • Abbott Laboratories
  • ACON Laboratories, Inc
  • AgaMatrix, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Medical Ltd.
  • Becton Dickinson and Company
  • Beurer Belgium
  • Dexcom, Inc.
  • ForaCare Suisse AG
  • i-SENS, Inc.
  • Johnson & Johnson
  • LifeScan IP Holdings, LLC
  • Medisana AG
  • Medtronic PLC
  • Merck KGaA
  • Microlife AG
  • Neogen Corporation
  • Nipro Corporation
  • Nova Biomedical
  • Omron Healthcare, Inc.
  • Roche Diagnostics Nederland BV
  • Rossmax International Ltd.
  • Sanofi S.A.
  • Sinocare Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • VivaChek Laboratories Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Glucose Testing Market, by Product Type
8.1. Introduction
8.2. Continuous Glucose Monitoring Devices
8.2.1. Receivers
8.2.2. Sensors
8.2.3. Transmitters
8.3. Self-Monitoring Blood Glucose Devices
8.3.1. Blood Glucose Meters
8.3.2. Lancets
8.3.3. Test Strips
9. Blood Glucose Testing Market, by Patient Type
9.1. Introduction
9.2. Patients With Type 1 Diabetes
9.2.1. Adults
9.2.2. Children
9.3. Patients With Type 2 Diabetes
9.3.1. Managed
9.3.2. Newly Diagnosed
10. Blood Glucose Testing Market, by Technology
10.1. Introduction
10.2. Electrochemical
10.3. Photometric
10.4. Spectroscopy Based
11. Blood Glucose Testing Market, by End-User
11.1. Introduction
11.2. Diagnostic Centers
11.2.1. Emergency Diagnostics
11.2.2. Routine Diagnostics
11.3. Homecare Settings
11.3.1. Home Self-Use
11.4. Hospitals and Clinics
11.4.1. Inpatient Testing
11.4.2. Outpatient Testing
11.5. Research Laboratories
11.5.1. Clinical Research
11.5.2. Product Development
12. Blood Glucose Testing Market, by Application
12.1. Introduction
12.2. Daily Tracking
12.2.1. Routine Monitoring
12.3. Emergency Monitoring
12.3.1. Critical Care Monitoring
12.4. Long-Term Monitoring
12.4.1. Clinical Evaluation
13. Blood Glucose Testing Market, by Component
13.1. Introduction
13.2. Hardware
13.2.1. Devices
13.2.2. Integrated Systems
13.3. Services
13.3.1. Installation and Setup
13.3.2. Maintenance and Warranty
13.4. Software
13.4.1. Mobile Applications
13.4.2. Web-Based Platforms
14. Blood Glucose Testing Market, by Distribution Channel
14.1. Introduction
14.2. Hospital Pharmacies
14.2.1. In-Hospital Pharmacies
14.3. Online Channels
14.3.1. E-Commerce Platforms
14.4. Retail Pharmacies
14.4.1. Chain Pharmacies
14.4.2. Independent Pharmacies
15. Blood Glucose Testing Market, by Age Group
15.1. Introduction
15.2. Adults
15.2.1. Middle-Aged
15.2.2. Young Adults
15.3. Geriatrics
15.3.1. Elderly
15.4. Pediatrics
15.4.1. Adolescents
15.4.2. Children
15.4.3. Neonates
16. Americas Blood Glucose Testing Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Blood Glucose Testing Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Blood Glucose Testing Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. 77 Elektronika Kft.
19.3.2. Abbott Laboratories
19.3.3. ACON Laboratories, Inc
19.3.4. AgaMatrix, Inc.
19.3.5. ARKRAY, Inc.
19.3.6. Ascensia Diabetes Care Holdings AG
19.3.7. B. Braun Medical Ltd.
19.3.8. Becton Dickinson and Company
19.3.9. Beurer Belgium
19.3.10. Dexcom, Inc.
19.3.11. ForaCare Suisse AG
19.3.12. i-SENS, Inc.
19.3.13. Johnson & Johnson
19.3.14. LifeScan IP Holdings, LLC
19.3.15. Medisana AG
19.3.16. Medtronic PLC
19.3.17. Merck KGaA
19.3.18. Microlife AG
19.3.19. Neogen Corporation
19.3.20. Nipro Corporation
19.3.21. Nova Biomedical
19.3.22. Omron Healthcare, Inc.
19.3.23. Roche Diagnostics Nederland BV
19.3.24. Rossmax International Ltd.
19.3.25. Sanofi S.A.
19.3.26. Sinocare Inc.
19.3.27. Terumo Corporation
19.3.28. Trividia Health, Inc.
19.3.29. VivaChek Laboratories Inc.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. BLOOD GLUCOSE TESTING MARKET MULTI-CURRENCY
FIGURE 2. BLOOD GLUCOSE TESTING MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD GLUCOSE TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. BLOOD GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. BLOOD GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY RECEIVERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TRANSMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY BLOOD GLUCOSE METERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY MANAGED, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY NEWLY DIAGNOSED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 2 DIABETES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PHOTOMETRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY SPECTROSCOPY BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY EMERGENCY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ROUTINE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME SELF-USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY INPATIENT TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DAILY TRACKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ROUTINE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DAILY TRACKING, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY EMERGENCY MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CRITICAL CARE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY EMERGENCY MONITORING, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY LONG-TERM MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CLINICAL EVALUATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY LONG-TERM MONITORING, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY INSTALLATION AND SETUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY MAINTENANCE AND WARRANTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY WEB-BASED PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY IN-HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY MIDDLE-AGED, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY NEONATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 2 DIABETES, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY DAILY TRACKING, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY EMERGENCY MONITORING, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY LONG-TERM MONITORING, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 2 DIABETES, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DAILY TRACKING, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY EMERGENCY MONITORING, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY LONG-TERM MONITORING, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 2 DIABETES, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY DAILY TRACKING, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY EMERGENCY MONITORING, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY LONG-TERM MONITORING, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 178. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 180. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 181. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 182. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 183. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 2 DIABETES, 2018-2030 (USD MILLION)
TABLE 184. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 187. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 188. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 189. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 190. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY DAILY TRACKING, 2018-2030 (USD MILLION)
TABLE 192. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY EMERGENCY MONITORING, 2018-2030 (USD MILLION)
TABLE 193. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY LONG-TERM MONITORING, 2018-2030 (USD MILLION)
TABLE 194. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 195. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 196. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 197. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 198. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 200. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 201. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 202. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 203. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 204. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 205. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 206. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 208. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 209. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 210. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 211. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 2 DIABETES, 2018-2030 (USD MILLION)
TABLE 212. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 215. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 216. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 217. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 218. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY DAILY TRACKING, 2018-2030 (USD MILLION)
TABLE 220. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY EMERGENCY MONITORING, 2018-2030 (USD MILLION)
TABLE 221. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY LONG-TERM MONITORING, 2018-2030 (USD MILLION)
TABLE 222. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 223. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 224. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 225. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 226. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 228. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 229. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 230. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 231. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 232. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 233. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 2 DIABETES, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 243. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 244. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 246. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DAILY TRACKING, 2018-2030 (USD MILLION)
TABLE 248. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY EMERGENCY MONITORING, 2018-2030 (USD MILLION)
TABLE 249. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY LONG-TERM MONITORING, 2018-2030 (USD MILLION)
TABLE 250. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 251. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 252. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 253. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 254. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 256. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 257. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 258. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 259. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 260. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 261. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 262. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 2 DIABETES, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY DAILY TRACKING, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY EMERGENCY MONITORING, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY LONG-TERM MONITORING, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 280. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 282. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 285. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 286. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 287. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 288. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 289. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 290. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 291. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 1 DIABETES, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENTS WITH TYPE 2 DIABETES, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DAILY TRACKING, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY EMERGENCY MONITORING, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY LONG-TERM MONITORING, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 309. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 310. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 311. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 312. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 314. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 315. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 316. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 317. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 318. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 319. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 320. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 321. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 322. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 323. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 324. CHINA BLOO

Companies Mentioned

  • 77 Elektronika Kft.
  • Abbott Laboratories
  • ACON Laboratories, Inc
  • AgaMatrix, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Medical Ltd.
  • Becton Dickinson and Company
  • Beurer Belgium
  • Dexcom, Inc.
  • ForaCare Suisse AG
  • i-SENS, Inc.
  • Johnson & Johnson
  • LifeScan IP Holdings, LLC
  • Medisana AG
  • Medtronic PLC
  • Merck KGaA
  • Microlife AG
  • Neogen Corporation
  • Nipro Corporation
  • Nova Biomedical
  • Omron Healthcare, Inc.
  • Roche Diagnostics Nederland BV
  • Rossmax International Ltd.
  • Sanofi S.A.
  • Sinocare Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • VivaChek Laboratories Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Blood Glucose Test Strips Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Blood Glucose Test Strips Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Blood Glucose Test Strips Market - Forecasts from 2024 to 2029 - Product Image

Blood Glucose Test Strips Market - Forecasts from 2024 to 2029

  • Report
  • 124 Pages
  • Global
From
Blood Glucose Test Strips - Global Strategic Business Report - Product Image

Blood Glucose Test Strips - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Blood Glucose Test Strips Market - Global Forecast to 2030 - Product Image

Blood Glucose Test Strips Market - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Blood Glucose Test Strip (BGTS) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Blood Glucose Test Strip (BGTS) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 91 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.